North Star Investment Management’s Axsome Therapeutics AXSM Stock Holding History

North Star Investment Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.2K	Hold	13	–	–	﹤0.01%	1397
2025 Q4	$2.37K	Hold	13	–	–	﹤0.01%	1297
2025 Q3	$1.58K	Hold	13	–	–	﹤0.01%	1138
2025 Q2	$1.36K	Hold	13	–	–	﹤0.01%	1119
2025 Q1	$1.52K	Hold	13	–	–	﹤0.01%	1105
2024 Q4	$1.1K	Hold	13	–	–	﹤0.01%	1149
2024 Q3	$1.17K	Hold	13	–	–	﹤0.01%	1117
2024 Q2	$1.05K	Hold	13	–	–	﹤0.01%	1092
2024 Q1	$1.04K	Hold	13	–	–	﹤0.01%	1154
2023 Q4	$1.03K	Hold	13	–	–	﹤0.01%	1107
2023 Q3	$909	Hold	13	–	–	﹤0.01%	1146
2023 Q2	$934	Hold	13	–	–	﹤0.01%	1160
2023 Q1	$802	Hold	13	–	–	﹤0.01%	1190
2022 Q4	$1K	Hold	13	–	–	﹤0.01%	1162
2022 Q3	$1K	Hold	13	–	–	﹤0.01%	1056
2022 Q2	$0	Hold	13	–	–	﹤0.01%	1133
2022 Q1	$1K	Hold	13	–	–	﹤0.01%	1078
2021 Q4	$0	Hold	13	–	–	﹤0.01%	1177
2021 Q3	$0	Hold	13	–	–	﹤0.01%	1124
2021 Q2	$1K	Hold	13	–	–	﹤0.01%	1040
2021 Q1	$1K	Sell	13 -100	-88%	-$7.03K	﹤0.01%	1002
2020 Q4	$9K	Buy	113 +13	+13%	+$972	﹤0.01%	786
2020 Q3	$7K	Hold	100	–	–	﹤0.01%	792
2020 Q2	$8K	Buy	+100	New	+$7.7K	﹤0.01%	750

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

North Star Investment Management's AXSM Position: Q1 2026 in Review

North Star Investment Management held its Axsome Therapeutics (AXSM) position steady in Q1 2026 at 13 shares worth $2.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

North Star Investment Management first reported a position in AXSM in Q2 2020 and has held it in 24 quarters since. The position peaked at $9K in Q4 2020. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

North Star Investment Management held 13 shares of Axsome Therapeutics worth $2.2K as of Q1 2026.
North Star Investment Management left its Axsome Therapeutics share count unchanged in Q1 2026.
Axsome Therapeutics made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #1397 holding.
North Star Investment Management first reported a position in Axsome Therapeutics in Q2 2020 and has held it in 24 quarters since.
North Star Investment Management's Axsome Therapeutics position peaked at $9K in Q4 2020.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.